267 related articles for article (PubMed ID: 29138577)
21. Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.
Yan H; Wen L; Tan D; Xie P; Pang FM; Zhou HH; Zhang W; Liu ZQ; Tang J; Li X; Chen XP
Oncotarget; 2017 Jan; 8(1):1529-1540. PubMed ID: 27903973
[TBL] [Abstract][Full Text] [Related]
22. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
23. SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients.
Liu F; Deng S; Li Y; Du J; Zeng H
Front Genet; 2022; 13():1081262. PubMed ID: 36685828
[No Abstract] [Full Text] [Related]
24. Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.
Li D; Liang J; Cheng C; Guo W; Li S; Song W; Song Z; Bai Y; Zhang Y; Wu X; Zhang W
Front Cell Dev Biol; 2021; 9():770451. PubMed ID: 34869365
[No Abstract] [Full Text] [Related]
25. Prognostic insights and immune microenvironment delineation in acute myeloid leukemia by ferroptosis-derived signature.
Jing L; Zhang B; Sun J; Feng J; Fu D
Heliyon; 2024 Mar; 10(6):e28237. PubMed ID: 38532996
[TBL] [Abstract][Full Text] [Related]
26. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.
Li X; Shi Y; Yin Z; Xue X; Zhou B
J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932
[TBL] [Abstract][Full Text] [Related]
27. Immune prognostic risk score model in acute myeloid leukemia with normal karyotype.
Dong X; Zhang D; Zhang J; Chen X; Zhang Y; Zhang Y; Zhou X; Chen T; Zhou H
Oncol Lett; 2020 Dec; 20(6):380. PubMed ID: 33154778
[TBL] [Abstract][Full Text] [Related]
28. A three-gene signature might predict prognosis in patients with acute myeloid leukemia.
Zhu X; Zhao Q; Su X; Ke J; Yi Y; Yi J; Lin J; Qian J; Deng Z
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436945
[TBL] [Abstract][Full Text] [Related]
29. Methylation of DNA Repair Genes as a Prognostic Biomarker in AML of a TCGA-LAML Cohort.
Park S; So MK; Huh J
Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975527
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a cuproptosis-related prognostic model for acute myeloid leukemia patients using machine learning with stacking.
Wang X; Sun H; Dong Y; Huang J; Bai L; Tang Z; Liu S; Chen S
Sci Rep; 2024 Feb; 14(1):2802. PubMed ID: 38307903
[TBL] [Abstract][Full Text] [Related]
31. The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
J Transl Med; 2021 May; 19(1):228. PubMed ID: 34051812
[TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of
Liu W; Zhu F; Yan J; Liu Y; Chen C; Zhang K; Zhao X; Chen J
Onco Targets Ther; 2020; 13():11165-11176. PubMed ID: 33173308
[TBL] [Abstract][Full Text] [Related]
33. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
[TBL] [Abstract][Full Text] [Related]
34. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma.
Zhou JG; Zhong H; Zhang J; Jin SH; Roudi R; Ma H
Front Oncol; 2019; 9():78. PubMed ID: 30828567
[No Abstract] [Full Text] [Related]
36. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
37. Development of a Prognostic Nomogram for Acute Myeloid Leukemia on
Qiu Q; Zhang P; Zhang N; Shen Y; Lou S; Deng J
Int J Gen Med; 2021; 14():4303-4316. PubMed ID: 34408473
[TBL] [Abstract][Full Text] [Related]
38. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients.
Zhu R; Tao H; Lin W; Tang L; Hu Y
Front Oncol; 2020; 10():574939. PubMed ID: 33330048
[TBL] [Abstract][Full Text] [Related]
39. Identification of a prognostic signature based on copy number variations (CNVs) and CNV-modulated gene expression in acute myeloid leukemia.
Niu C; Wu D; Li AJ; Qin KH; Hu DA; Wang EJ; Tucker AB; He F; Huang L; Wang H; Liu Q; Ni N; Shi D; Zhao X; Wan Y; Li T; He T; Liao P
Am J Transl Res; 2021; 13(12):13683-13696. PubMed ID: 35035707
[TBL] [Abstract][Full Text] [Related]
40. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
